Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...
The US Food and Drug Administration (FDA) issued a proposed rule on Monday to remove the required testing method to detect the presence of Mycoplasma because FDA said the regulation is restrictive in ...
Indications : Culture isolation of M. pneumoniae is a tedious and laborious process. Diagnosis through molecular methods is specific and sensitive and is hence the preferred method to detect this ...
This is driving the demand for mycoplasma test kits. Rapid mycoplasma test kits are commercially available in the market that can be used in research labs and biopharmaceutical manufacturing companies ...
Eurofins Lancaster Laboratories has launched a new validated Rapid Mycoplasma Detection Test, overcoming time-consuming challenges of the standard 28-day compendial method for mycoplasma testing. For ...
Roche's MycoTOOL, which offers rapid detection of mycoplasms based on a polymerase chain reaction (PCR) test, has received FDA acceptance. Mycoplasma contamination is a common and significant issue in ...
Today Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche's biological ...
he Health Ministry is gearing up its laboratory network to diagnose symptoms of mycoplasma pneumonia, Health Minister Budi Gunadi Sadikin announced at the Sudirman Institute in Jakarta on Monday. "We ...
Mycoplasma contamination of manufacturing cell cultures is rare, but presents a threat for biologics manufacturers. Traditionally, testing was done using a culture-based, 28-day mycoplasma test. More ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results